𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ergoline and non-ergoline derivatives in the treatment of Parkinson’s disease

✍ Scribed by Heinz Reichmann; Anja Bilsing; Reinhard Ehret; Wolfgang Greulich; Jörg B. Schulz; Andreas Schwartz; Olivier Rascol

Publisher
Springer
Year
2006
Tongue
English
Weight
189 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hiccups associated with non-ergoline dop
Hiccups associated with non-ergoline dopamine agonists in Parkinson's disease
✍ Mario Coletti Moja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

Nothing to disclose. Author Roles: Mohammed T. Ahmad was involved in the writing of the first draft, patient assessment, followup, and video filming. Kumar M. Prakash was involved in review and critique, writing of the final draft, patient and video assessment, and video editing.

Viral vectors in the treatment of Parkin
Viral vectors in the treatment of Parkinson's disease
✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro